Professor & Director
UTHSC at Memphis
Memphis, Tennessee, United States
Pathophysiology of kidney disease in sickle cell disease and sickle cell trait
Friday, May 3, 2024
5:15 PM – 5:40 PM ET
Disclosure(s): Agios Pharmaceuticals (Ongoing) (Products/Services: Advisory Committee); Biomarin (Terminated, January 31, 2024) (Products/Services: Advisory Committee, Consultant); Fulcrum Therapeutics (Ongoing) (Products/Services: Advisory Committee); GSK (Ongoing) (Products/Services: Advisory Committee); Hillhurst Biopharmaceuticals (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Novo Nordisk (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Advisory Committee); Sanofi (Ongoing) (Products/Services: Advisory Committee)